Table 6 Adverse events during treatment.
Adverse reaction | IFN gamma N = 18 | Placebo N = 14 |
|---|---|---|
Any adverse event | 12 (66.7%) | 6 (42.9%) |
Arthralgias | 9 (50%) | 2 (14.3%) |
Fever | 8 (44.4%) | 0 |
Chills | 6 (33.3%) | 0 |
Anorexia | 5 (27.8%) | 2 (14.3%) |
Asthenia | 4 (22.2%) | 0 |
Headache | 3 (16.7%) | 0 |
Diarrhea | 2 (11.1%) | 1 (7.1%) |
Pruritus | 2 (11,1%) | 1 (7.1%) |
Epigastralgia | 1 (5.6%) | 1 (7.1%) |
Myalgias | 0 | 1 (7.1%) |
Vomiting | 1 (5.6%) | 0 |
Depression | 0 | 1 (7.1%) |
Anemia | 1 (5.6%) | 0 |
Pain at the injection site | 1 (5.6%) | 0 |
Increase of creatinine | 1 (5.6%) | 0 |
Limb edema | 0 | 1 (7.1%) |
Nausea | 0 | 1 (7.1%) |